[
  {
    "ts": null,
    "headline": "ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL",
    "summary": "AbbVie and Genmab’s Epkinly triplet is poised to become a new standard of care for FL.",
    "url": "https://finnhub.io/api/news?id=0d4c9e90ad98ee5734c3dd61c9a8805dbb5ace8682636a8e60dc7877ce6b999c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765388442,
      "headline": "ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL",
      "id": 137749922,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "AbbVie and Genmab’s Epkinly triplet is poised to become a new standard of care for FL.",
      "url": "https://finnhub.io/api/news?id=0d4c9e90ad98ee5734c3dd61c9a8805dbb5ace8682636a8e60dc7877ce6b999c"
    }
  },
  {
    "ts": null,
    "headline": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
    "summary": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=b0e842c8ea1c5cce103534f29518eb9c1f9f66e4ff0a34b2c3af85a742deb45c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765377600,
      "headline": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
      "id": 137749925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=b0e842c8ea1c5cce103534f29518eb9c1f9f66e4ff0a34b2c3af85a742deb45c"
    }
  },
  {
    "ts": null,
    "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-point rate hike. The worry hanging over traders is that many fear a “hawkish rate cut.” Where they do cut 25 basis ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
    "url": "https://finnhub.io/api/news?id=894e11783022f0ab66ac1975da95caa3723a9bc1b92d20095a49fcd3e00116dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765375761,
      "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
      "id": 137749926,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-point rate hike. The worry hanging over traders is that many fear a “hawkish rate cut.” Where they do cut 25 basis ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More",
      "url": "https://finnhub.io/api/news?id=894e11783022f0ab66ac1975da95caa3723a9bc1b92d20095a49fcd3e00116dc"
    }
  },
  {
    "ts": null,
    "headline": "Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner",
    "summary": "GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--Great Point Partners (\"GPP\" or \"the Firm\"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group (\"Lenis\" or \"the Company\"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe (\"CEE\").",
    "url": "https://finnhub.io/api/news?id=a94c262f37aa5b00911a2a921035ca099e5bb66b5803d5895917e8126e2d04c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765375200,
      "headline": "Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner",
      "id": 137750880,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "GREENWICH, Conn. & LJUBLJANA, Slovenia, December 10, 2025--Great Point Partners (\"GPP\" or \"the Firm\"), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group (\"Lenis\" or \"the Company\"), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe (\"CEE\").",
      "url": "https://finnhub.io/api/news?id=a94c262f37aa5b00911a2a921035ca099e5bb66b5803d5895917e8126e2d04c1"
    }
  },
  {
    "ts": null,
    "headline": "HSBC highlights one pharma stock to buy and one to sell for 2026",
    "summary": "Investing.com -- HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank refreshed its 2026 sector outlook.",
    "url": "https://finnhub.io/api/news?id=577018d29150f231ee24cc4eae8caf159a420b69210012fe907d5903f28b1516",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765373818,
      "headline": "HSBC highlights one pharma stock to buy and one to sell for 2026",
      "id": 137749927,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Investing.com -- HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank refreshed its 2026 sector outlook.",
      "url": "https://finnhub.io/api/news?id=577018d29150f231ee24cc4eae8caf159a420b69210012fe907d5903f28b1516"
    }
  }
]